MGC Diagnostics (MGCD) Reports Q4 Loss of $0.94

MGC Diagnostics (NASDAQ: MGCD) reported Q4 EPS of ($0.94), versus $0.24 reported last year. Revenue for the quarter came in at $11.5 million, versus $10.6 million reported last year.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• RCM Technologies (RCMT) Tops Q2 EPS by 17c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance